Black Diamond Therapeutics Inc (BDTX)
$2.44 $0.08 (3.35%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$136.37M -
Day's Range
$2.34 - $2.52 -
Volume
469,494 -
52 Week Low / High
$2.31 - $7.66 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
BDTX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $11.33
- Target Price
Company News
-
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug — Sep 23rd, 2024
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug Monday, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) reported initial Phase 2 data of BDTX-1535. The data demonstrated encouraging clinical r...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$